Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers
-
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Update
-
Precious Metals & Critical Minerals Hybrid Investor Conference Agenda Announced for May 21st
-
Viva Gold to Present at the Precious Metals & Critical Minerals Hybrid Investor Conference on May 21, 2026
-
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Im
-
Star Gold Corp., to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 21st
-
BNP Paribas Primary New Issues: STAB Notice
-
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
-
20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026
-
Helport AI Launches New ‘AI Labor’ Corporate Website
-
Lakeland Fire + Safety’s LHD Group Australia Secures Multi-Year Extension Agreement with Energy Queensland for Field Workwear
-
Phunware Appoints Dmitry Kroshka as Chief Executive Officer to Lead 2.0 Strategy; Engages Michael Cerdá to Drive Product Rollout
-
Splash Beverage Group Announces Leadership Transition and Strategic Evolution Toward High-Growth Wellness & Cannabinoid Markets
-
GoldHaven Announces Phase II Drill Program at Copeçal as Independent Review Identifies Multiple Mineralization Vectors
-
Cartier Delivers Metallurgical Results Exceeding Expectations with 96.3% Gold Recovery at Cadillac
-
REPEAT – Dorel Industries Inc. Announces Virtual Annual Meeting of Shareholders
-
OFA Group Enters $7.5 Million Tokenization Platform Services Agreement for Vero Beach, Florida Residential Development Project
-
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
-
Snail Games USA Explores Partnerships in One of Gaming’s Largest Markets with Gamescom LATAM Attendance
-
Morien Announces Results of Annual and Special Meeting
-
Live Ventures Reports Fiscal Second Quarter 2026 Financial Results
-
Biodexa issues letter to Shareholders
-
SPARC AI Inc. (OTC: SPAIF) Leading Out in Filling Gap, Developing Software-Only Drone System
-
FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH
-
C3is Inc. announces the date for the release of the first quarter 2026 financial and operating results
-
XTEND Secures Seven-Figure Defense ISR Order in Asia-Pacific
-
Jupiter Festival Launches a New Global Forum for Media, Entertainment and Sports Leaders Shaping the Future of Content
-
Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
-
Splash Beverage Group Announces Leadership Transition and Strategic Evolution Toward High-Growth Wellness & Cannabinoid Markets
-
Fusemachines Research Shows How Agentic AI Is Becoming Core to Enterprise Hiring
-
SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Developing Distinct Next-Gen GLP-1 Built Around Novel Peptide
-
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
-
Onfolio to Target $5-10 Million in EBITDA Acquisitions as AI Creates New Buying Opportunities
-
CapeHaven Completes First Close of Funding and Initiates Operations to Encourage Yale’s Biotech Spinouts
-
Vor Bio Announces Publication of Interim Analysis of TELIGAN, a China Phase 3 Trial of Telitacicept in IgA Nephropathy, in The New England Journal of Medicine
-
Forge Nano Delivers Semiconductor Wafer Fab Equipment to Leading Fortune Global 500 Communications Company for Commercial Photonics Applications
-
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
-
Dogwood Therapeutics Announces First Quarter 2026 Financial Results
-
Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label
-
Alarum to Release First Quarter 2026 Results and Host Conference Call on Thursday, May 28, 2026
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
-
ZBAI Announces Change of its Nasdaq Ticker Symbol to “AUC”
-
HYCU® Wakes up Backup with aiR™; Launch Adds New AI Capabilities Across Protected Systems of Record Within Its Market-leading R-Cloud Resilience Platform
-
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Harnesses Key AI, Voice Analysis to Offer Impairment Solution
-
Cycurion Reports First Quarter 2026 Results
-
Exol Announces Strategic Partnership with Manhattan Associates to Unify and Transform Supply Chain Execution
-
Jackery Brings the Power and Savings to Memorial Day Weekend
-
The Other Side of the Nuclear Renaissance: How Domestic Uranium Lands on the Pre-Feasibility Calendar
-
The Quiet Consolidation of a Defense AI Platform
-
Free Call Tracking Software switch.monster Helps Businesses Connect PPC Clicks, Google Ads and Phone Leads
